nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitaxentan—EDNRA—atherosclerosis	0.528	1	CbGaD
Sitaxentan—CYP2C19—Rosuvastatin—atherosclerosis	0.0356	0.121	CbGbCtD
Sitaxentan—CYP2C19—Simvastatin—atherosclerosis	0.0331	0.113	CbGbCtD
Sitaxentan—CYP2C19—Lovastatin—atherosclerosis	0.0324	0.11	CbGbCtD
Sitaxentan—CYP2C9—Rosuvastatin—atherosclerosis	0.0296	0.101	CbGbCtD
Sitaxentan—CYP2C9—Simvastatin—atherosclerosis	0.0276	0.0937	CbGbCtD
Sitaxentan—CYP2C9—Lovastatin—atherosclerosis	0.027	0.0917	CbGbCtD
Sitaxentan—CYP2C9—Pravastatin—atherosclerosis	0.027	0.0917	CbGbCtD
Sitaxentan—CYP3A4—Rosuvastatin—atherosclerosis	0.0172	0.0586	CbGbCtD
Sitaxentan—CYP3A4—Ezetimibe—atherosclerosis	0.0172	0.0586	CbGbCtD
Sitaxentan—CYP3A4—Simvastatin—atherosclerosis	0.016	0.0545	CbGbCtD
Sitaxentan—CYP3A4—Pravastatin—atherosclerosis	0.0157	0.0533	CbGbCtD
Sitaxentan—CYP3A4—Lovastatin—atherosclerosis	0.0157	0.0533	CbGbCtD
Sitaxentan—Hepatitis—Rosuvastatin—atherosclerosis	0.000304	0.00279	CcSEcCtD
Sitaxentan—Eosinophilia—Simvastatin—atherosclerosis	0.000298	0.00274	CcSEcCtD
Sitaxentan—Liver function test abnormal—Niacin—atherosclerosis	0.000296	0.00271	CcSEcCtD
Sitaxentan—Photosensitivity reaction—Lovastatin—atherosclerosis	0.000294	0.0027	CcSEcCtD
Sitaxentan—Dry skin—Niacin—atherosclerosis	0.000294	0.00269	CcSEcCtD
Sitaxentan—Orthostatic hypotension—Niacin—atherosclerosis	0.000293	0.00268	CcSEcCtD
Sitaxentan—Liver function test abnormal—Pravastatin—atherosclerosis	0.000291	0.00267	CcSEcCtD
Sitaxentan—Bronchitis—Simvastatin—atherosclerosis	0.00029	0.00266	CcSEcCtD
Sitaxentan—Dry skin—Pravastatin—atherosclerosis	0.000289	0.00265	CcSEcCtD
Sitaxentan—Abdominal discomfort—Simvastatin—atherosclerosis	0.000289	0.00265	CcSEcCtD
Sitaxentan—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.000289	0.00265	CcSEcCtD
Sitaxentan—Cramp muscle—Pravastatin—atherosclerosis	0.000284	0.00261	CcSEcCtD
Sitaxentan—Muscular weakness—Niacin—atherosclerosis	0.000282	0.00259	CcSEcCtD
Sitaxentan—Infestation NOS—Ezetimibe—atherosclerosis	0.000282	0.00259	CcSEcCtD
Sitaxentan—Infestation—Ezetimibe—atherosclerosis	0.000282	0.00259	CcSEcCtD
Sitaxentan—Muscular weakness—Pravastatin—atherosclerosis	0.000278	0.00255	CcSEcCtD
Sitaxentan—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.000278	0.00255	CcSEcCtD
Sitaxentan—Photosensitivity reaction—Simvastatin—atherosclerosis	0.000275	0.00252	CcSEcCtD
Sitaxentan—Jaundice—Ezetimibe—atherosclerosis	0.000275	0.00252	CcSEcCtD
Sitaxentan—Eosinophilia—Pravastatin—atherosclerosis	0.00027	0.00248	CcSEcCtD
Sitaxentan—Angina pectoris—Niacin—atherosclerosis	0.00027	0.00247	CcSEcCtD
Sitaxentan—Sinusitis—Lovastatin—atherosclerosis	0.00027	0.00247	CcSEcCtD
Sitaxentan—Mental disorder—Rosuvastatin—atherosclerosis	0.000267	0.00245	CcSEcCtD
Sitaxentan—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.000267	0.00245	CcSEcCtD
Sitaxentan—Bronchitis—Niacin—atherosclerosis	0.000266	0.00244	CcSEcCtD
Sitaxentan—Angina pectoris—Pravastatin—atherosclerosis	0.000265	0.00244	CcSEcCtD
Sitaxentan—Sinusitis—Ezetimibe—atherosclerosis	0.000264	0.00243	CcSEcCtD
Sitaxentan—Jaundice—Simvastatin—atherosclerosis	0.000262	0.0024	CcSEcCtD
Sitaxentan—Hepatitis—Lovastatin—atherosclerosis	0.000258	0.00237	CcSEcCtD
Sitaxentan—Dysuria—Pravastatin—atherosclerosis	0.000255	0.00234	CcSEcCtD
Sitaxentan—Hepatitis—Ezetimibe—atherosclerosis	0.000253	0.00232	CcSEcCtD
Sitaxentan—Sinusitis—Simvastatin—atherosclerosis	0.000252	0.00231	CcSEcCtD
Sitaxentan—Oedema peripheral—Ezetimibe—atherosclerosis	0.000249	0.00229	CcSEcCtD
Sitaxentan—Photosensitivity reaction—Pravastatin—atherosclerosis	0.000249	0.00228	CcSEcCtD
Sitaxentan—Weight decreased—Pravastatin—atherosclerosis	0.000247	0.00226	CcSEcCtD
Sitaxentan—Hepatitis—Simvastatin—atherosclerosis	0.000241	0.00221	CcSEcCtD
Sitaxentan—Stomatitis—Niacin—atherosclerosis	0.000241	0.00221	CcSEcCtD
Sitaxentan—Jaundice—Niacin—atherosclerosis	0.000241	0.00221	CcSEcCtD
Sitaxentan—Acute coronary syndrome—Pravastatin—atherosclerosis	0.00024	0.0022	CcSEcCtD
Sitaxentan—Flushing—Lovastatin—atherosclerosis	0.000239	0.0022	CcSEcCtD
Sitaxentan—Myocardial infarction—Pravastatin—atherosclerosis	0.000238	0.00219	CcSEcCtD
Sitaxentan—Jaundice—Pravastatin—atherosclerosis	0.000237	0.00217	CcSEcCtD
Sitaxentan—Flushing—Ezetimibe—atherosclerosis	0.000235	0.00215	CcSEcCtD
Sitaxentan—Angiopathy—Ezetimibe—atherosclerosis	0.00023	0.00211	CcSEcCtD
Sitaxentan—Immune system disorder—Ezetimibe—atherosclerosis	0.000229	0.0021	CcSEcCtD
Sitaxentan—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000228	0.00209	CcSEcCtD
Sitaxentan—Sinusitis—Pravastatin—atherosclerosis	0.000228	0.00209	CcSEcCtD
Sitaxentan—Alopecia—Lovastatin—atherosclerosis	0.000228	0.00209	CcSEcCtD
Sitaxentan—Flushing—Simvastatin—atherosclerosis	0.000224	0.00205	CcSEcCtD
Sitaxentan—Alopecia—Ezetimibe—atherosclerosis	0.000224	0.00205	CcSEcCtD
Sitaxentan—Haemoglobin—Niacin—atherosclerosis	0.000223	0.00204	CcSEcCtD
Sitaxentan—Rhinitis—Niacin—atherosclerosis	0.000222	0.00204	CcSEcCtD
Sitaxentan—Mental disorder—Ezetimibe—atherosclerosis	0.000222	0.00203	CcSEcCtD
Sitaxentan—Haemorrhage—Niacin—atherosclerosis	0.000222	0.00203	CcSEcCtD
Sitaxentan—Hepatitis—Niacin—atherosclerosis	0.000222	0.00203	CcSEcCtD
Sitaxentan—Malnutrition—Ezetimibe—atherosclerosis	0.00022	0.00202	CcSEcCtD
Sitaxentan—Rhinitis—Pravastatin—atherosclerosis	0.000219	0.00201	CcSEcCtD
Sitaxentan—Oedema peripheral—Niacin—atherosclerosis	0.000218	0.002	CcSEcCtD
Sitaxentan—Hepatitis—Pravastatin—atherosclerosis	0.000218	0.002	CcSEcCtD
Sitaxentan—Confusional state—Rosuvastatin—atherosclerosis	0.000218	0.002	CcSEcCtD
Sitaxentan—Muscle spasms—Lovastatin—atherosclerosis	0.000216	0.00198	CcSEcCtD
Sitaxentan—Infection—Rosuvastatin—atherosclerosis	0.000215	0.00197	CcSEcCtD
Sitaxentan—Visual impairment—Niacin—atherosclerosis	0.000214	0.00196	CcSEcCtD
Sitaxentan—Alopecia—Simvastatin—atherosclerosis	0.000213	0.00196	CcSEcCtD
Sitaxentan—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000212	0.00195	CcSEcCtD
Sitaxentan—Muscle spasms—Ezetimibe—atherosclerosis	0.000212	0.00194	CcSEcCtD
Sitaxentan—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000212	0.00194	CcSEcCtD
Sitaxentan—Mental disorder—Simvastatin—atherosclerosis	0.000211	0.00194	CcSEcCtD
Sitaxentan—Tremor—Lovastatin—atherosclerosis	0.00021	0.00193	CcSEcCtD
Sitaxentan—Visual impairment—Pravastatin—atherosclerosis	0.00021	0.00193	CcSEcCtD
Sitaxentan—Ill-defined disorder—Lovastatin—atherosclerosis	0.000208	0.00191	CcSEcCtD
Sitaxentan—Eye disorder—Niacin—atherosclerosis	0.000207	0.0019	CcSEcCtD
Sitaxentan—Tinnitus—Niacin—atherosclerosis	0.000207	0.0019	CcSEcCtD
Sitaxentan—Flushing—Niacin—atherosclerosis	0.000206	0.00189	CcSEcCtD
Sitaxentan—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000204	0.00187	CcSEcCtD
Sitaxentan—Anaemia—Ezetimibe—atherosclerosis	0.000204	0.00187	CcSEcCtD
Sitaxentan—Tinnitus—Pravastatin—atherosclerosis	0.000203	0.00187	CcSEcCtD
Sitaxentan—Malaise—Lovastatin—atherosclerosis	0.000203	0.00186	CcSEcCtD
Sitaxentan—Flushing—Pravastatin—atherosclerosis	0.000202	0.00186	CcSEcCtD
Sitaxentan—Cardiac disorder—Pravastatin—atherosclerosis	0.000202	0.00186	CcSEcCtD
Sitaxentan—Muscle spasms—Simvastatin—atherosclerosis	0.000202	0.00185	CcSEcCtD
Sitaxentan—Vertigo—Lovastatin—atherosclerosis	0.000202	0.00185	CcSEcCtD
Sitaxentan—Angiopathy—Niacin—atherosclerosis	0.000201	0.00184	CcSEcCtD
Sitaxentan—Leukopenia—Lovastatin—atherosclerosis	0.000201	0.00184	CcSEcCtD
Sitaxentan—Malaise—Ezetimibe—atherosclerosis	0.000199	0.00182	CcSEcCtD
Sitaxentan—Tremor—Simvastatin—atherosclerosis	0.000197	0.00181	CcSEcCtD
Sitaxentan—Alopecia—Niacin—atherosclerosis	0.000196	0.0018	CcSEcCtD
Sitaxentan—Insomnia—Rosuvastatin—atherosclerosis	0.000196	0.00179	CcSEcCtD
Sitaxentan—Ill-defined disorder—Simvastatin—atherosclerosis	0.000195	0.00179	CcSEcCtD
Sitaxentan—Anaemia—Simvastatin—atherosclerosis	0.000194	0.00178	CcSEcCtD
Sitaxentan—Malnutrition—Niacin—atherosclerosis	0.000193	0.00177	CcSEcCtD
Sitaxentan—Alopecia—Pravastatin—atherosclerosis	0.000193	0.00177	CcSEcCtD
Sitaxentan—Chest pain—Lovastatin—atherosclerosis	0.000191	0.00175	CcSEcCtD
Sitaxentan—Dyspepsia—Rosuvastatin—atherosclerosis	0.00019	0.00175	CcSEcCtD
Sitaxentan—Malaise—Simvastatin—atherosclerosis	0.000189	0.00174	CcSEcCtD
Sitaxentan—Tension—Niacin—atherosclerosis	0.000189	0.00174	CcSEcCtD
Sitaxentan—Discomfort—Lovastatin—atherosclerosis	0.000189	0.00173	CcSEcCtD
Sitaxentan—Vertigo—Simvastatin—atherosclerosis	0.000189	0.00173	CcSEcCtD
Sitaxentan—Leukopenia—Simvastatin—atherosclerosis	0.000188	0.00172	CcSEcCtD
Sitaxentan—Chest pain—Ezetimibe—atherosclerosis	0.000188	0.00172	CcSEcCtD
Sitaxentan—Nervousness—Niacin—atherosclerosis	0.000187	0.00172	CcSEcCtD
Sitaxentan—Dry mouth—Lovastatin—atherosclerosis	0.000187	0.00172	CcSEcCtD
Sitaxentan—Tension—Pravastatin—atherosclerosis	0.000186	0.00171	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000186	0.00171	CcSEcCtD
Sitaxentan—Muscle spasms—Niacin—atherosclerosis	0.000185	0.0017	CcSEcCtD
Sitaxentan—Discomfort—Ezetimibe—atherosclerosis	0.000185	0.0017	CcSEcCtD
Sitaxentan—Constipation—Rosuvastatin—atherosclerosis	0.000185	0.0017	CcSEcCtD
Sitaxentan—Pain—Rosuvastatin—atherosclerosis	0.000185	0.0017	CcSEcCtD
Sitaxentan—Confusional state—Lovastatin—atherosclerosis	0.000185	0.0017	CcSEcCtD
Sitaxentan—Nervousness—Pravastatin—atherosclerosis	0.000184	0.00169	CcSEcCtD
Sitaxentan—Dry mouth—Ezetimibe—atherosclerosis	0.000183	0.00168	CcSEcCtD
Sitaxentan—Muscle spasms—Pravastatin—atherosclerosis	0.000183	0.00167	CcSEcCtD
Sitaxentan—Infection—Lovastatin—atherosclerosis	0.000182	0.00167	CcSEcCtD
Sitaxentan—Confusional state—Ezetimibe—atherosclerosis	0.000181	0.00166	CcSEcCtD
Sitaxentan—Thrombocytopenia—Lovastatin—atherosclerosis	0.000179	0.00165	CcSEcCtD
Sitaxentan—Chest pain—Simvastatin—atherosclerosis	0.000179	0.00164	CcSEcCtD
Sitaxentan—Infection—Ezetimibe—atherosclerosis	0.000179	0.00164	CcSEcCtD
Sitaxentan—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000178	0.00163	CcSEcCtD
Sitaxentan—Tremor—Pravastatin—atherosclerosis	0.000178	0.00163	CcSEcCtD
Sitaxentan—Discomfort—Simvastatin—atherosclerosis	0.000177	0.00162	CcSEcCtD
Sitaxentan—Nervous system disorder—Ezetimibe—atherosclerosis	0.000176	0.00162	CcSEcCtD
Sitaxentan—Ill-defined disorder—Pravastatin—atherosclerosis	0.000176	0.00162	CcSEcCtD
Sitaxentan—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000176	0.00161	CcSEcCtD
Sitaxentan—Anaemia—Pravastatin—atherosclerosis	0.000176	0.00161	CcSEcCtD
Sitaxentan—Anorexia—Lovastatin—atherosclerosis	0.000175	0.0016	CcSEcCtD
Sitaxentan—Skin disorder—Ezetimibe—atherosclerosis	0.000175	0.0016	CcSEcCtD
Sitaxentan—Vertigo—Niacin—atherosclerosis	0.000173	0.00159	CcSEcCtD
Sitaxentan—Confusional state—Simvastatin—atherosclerosis	0.000173	0.00159	CcSEcCtD
Sitaxentan—Leukopenia—Niacin—atherosclerosis	0.000173	0.00158	CcSEcCtD
Sitaxentan—Urticaria—Rosuvastatin—atherosclerosis	0.000172	0.00158	CcSEcCtD
Sitaxentan—Oedema—Simvastatin—atherosclerosis	0.000171	0.00157	CcSEcCtD
Sitaxentan—Malaise—Pravastatin—atherosclerosis	0.000171	0.00157	CcSEcCtD
Sitaxentan—Vertigo—Pravastatin—atherosclerosis	0.000171	0.00157	CcSEcCtD
Sitaxentan—Infection—Simvastatin—atherosclerosis	0.00017	0.00156	CcSEcCtD
Sitaxentan—Leukopenia—Pravastatin—atherosclerosis	0.00017	0.00156	CcSEcCtD
Sitaxentan—Thrombocytopenia—Simvastatin—atherosclerosis	0.000168	0.00154	CcSEcCtD
Sitaxentan—Insomnia—Lovastatin—atherosclerosis	0.000166	0.00152	CcSEcCtD
Sitaxentan—Anorexia—Simvastatin—atherosclerosis	0.000163	0.0015	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000163	0.0015	CcSEcCtD
Sitaxentan—Insomnia—Ezetimibe—atherosclerosis	0.000163	0.00149	CcSEcCtD
Sitaxentan—Chest pain—Pravastatin—atherosclerosis	0.000162	0.00148	CcSEcCtD
Sitaxentan—Dyspepsia—Lovastatin—atherosclerosis	0.000161	0.00148	CcSEcCtD
Sitaxentan—Dry mouth—Niacin—atherosclerosis	0.000161	0.00147	CcSEcCtD
Sitaxentan—Discomfort—Pravastatin—atherosclerosis	0.00016	0.00147	CcSEcCtD
Sitaxentan—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000159	0.00146	CcSEcCtD
Sitaxentan—Decreased appetite—Lovastatin—atherosclerosis	0.000159	0.00146	CcSEcCtD
Sitaxentan—Dyspepsia—Ezetimibe—atherosclerosis	0.000158	0.00145	CcSEcCtD
Sitaxentan—Fatigue—Lovastatin—atherosclerosis	0.000158	0.00145	CcSEcCtD
Sitaxentan—Oedema—Niacin—atherosclerosis	0.000157	0.00144	CcSEcCtD
Sitaxentan—Pain—Lovastatin—atherosclerosis	0.000157	0.00144	CcSEcCtD
Sitaxentan—Constipation—Lovastatin—atherosclerosis	0.000157	0.00144	CcSEcCtD
Sitaxentan—Confusional state—Pravastatin—atherosclerosis	0.000156	0.00143	CcSEcCtD
Sitaxentan—Decreased appetite—Ezetimibe—atherosclerosis	0.000156	0.00143	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000155	0.00142	CcSEcCtD
Sitaxentan—Asthenia—Rosuvastatin—atherosclerosis	0.000155	0.00142	CcSEcCtD
Sitaxentan—Insomnia—Simvastatin—atherosclerosis	0.000155	0.00142	CcSEcCtD
Sitaxentan—Oedema—Pravastatin—atherosclerosis	0.000155	0.00142	CcSEcCtD
Sitaxentan—Fatigue—Ezetimibe—atherosclerosis	0.000155	0.00142	CcSEcCtD
Sitaxentan—Infection—Pravastatin—atherosclerosis	0.000154	0.00141	CcSEcCtD
Sitaxentan—Constipation—Ezetimibe—atherosclerosis	0.000154	0.00141	CcSEcCtD
Sitaxentan—Pain—Ezetimibe—atherosclerosis	0.000154	0.00141	CcSEcCtD
Sitaxentan—Tachycardia—Niacin—atherosclerosis	0.000154	0.00141	CcSEcCtD
Sitaxentan—Skin disorder—Niacin—atherosclerosis	0.000153	0.0014	CcSEcCtD
Sitaxentan—Thrombocytopenia—Pravastatin—atherosclerosis	0.000152	0.00139	CcSEcCtD
Sitaxentan—Feeling abnormal—Lovastatin—atherosclerosis	0.000151	0.00139	CcSEcCtD
Sitaxentan—Dyspepsia—Simvastatin—atherosclerosis	0.000151	0.00138	CcSEcCtD
Sitaxentan—Anorexia—Niacin—atherosclerosis	0.00015	0.00138	CcSEcCtD
Sitaxentan—Decreased appetite—Simvastatin—atherosclerosis	0.000149	0.00137	CcSEcCtD
Sitaxentan—Feeling abnormal—Ezetimibe—atherosclerosis	0.000148	0.00136	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000148	0.00136	CcSEcCtD
Sitaxentan—Diarrhoea—Rosuvastatin—atherosclerosis	0.000148	0.00136	CcSEcCtD
Sitaxentan—Fatigue—Simvastatin—atherosclerosis	0.000148	0.00136	CcSEcCtD
Sitaxentan—Anorexia—Pravastatin—atherosclerosis	0.000148	0.00136	CcSEcCtD
Sitaxentan—Hypotension—Niacin—atherosclerosis	0.000147	0.00135	CcSEcCtD
Sitaxentan—Constipation—Simvastatin—atherosclerosis	0.000147	0.00134	CcSEcCtD
Sitaxentan—Pain—Simvastatin—atherosclerosis	0.000147	0.00134	CcSEcCtD
Sitaxentan—Urticaria—Lovastatin—atherosclerosis	0.000146	0.00134	CcSEcCtD
Sitaxentan—Body temperature increased—Lovastatin—atherosclerosis	0.000145	0.00133	CcSEcCtD
Sitaxentan—Dizziness—Rosuvastatin—atherosclerosis	0.000143	0.00131	CcSEcCtD
Sitaxentan—Urticaria—Ezetimibe—atherosclerosis	0.000143	0.00131	CcSEcCtD
Sitaxentan—Insomnia—Niacin—atherosclerosis	0.000142	0.00131	CcSEcCtD
Sitaxentan—Body temperature increased—Ezetimibe—atherosclerosis	0.000142	0.0013	CcSEcCtD
Sitaxentan—Feeling abnormal—Simvastatin—atherosclerosis	0.000141	0.0013	CcSEcCtD
Sitaxentan—Insomnia—Pravastatin—atherosclerosis	0.00014	0.00129	CcSEcCtD
Sitaxentan—Somnolence—Niacin—atherosclerosis	0.00014	0.00128	CcSEcCtD
Sitaxentan—Dyspepsia—Niacin—atherosclerosis	0.000139	0.00127	CcSEcCtD
Sitaxentan—Decreased appetite—Niacin—atherosclerosis	0.000137	0.00126	CcSEcCtD
Sitaxentan—Dyspepsia—Pravastatin—atherosclerosis	0.000136	0.00125	CcSEcCtD
Sitaxentan—Rash—Rosuvastatin—atherosclerosis	0.000136	0.00125	CcSEcCtD
Sitaxentan—Dermatitis—Rosuvastatin—atherosclerosis	0.000136	0.00125	CcSEcCtD
Sitaxentan—Urticaria—Simvastatin—atherosclerosis	0.000136	0.00125	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Niacin—atherosclerosis	0.000136	0.00125	CcSEcCtD
Sitaxentan—Body temperature increased—Simvastatin—atherosclerosis	0.000136	0.00124	CcSEcCtD
Sitaxentan—Headache—Rosuvastatin—atherosclerosis	0.000135	0.00124	CcSEcCtD
Sitaxentan—Hypersensitivity—Lovastatin—atherosclerosis	0.000135	0.00124	CcSEcCtD
Sitaxentan—Decreased appetite—Pravastatin—atherosclerosis	0.000135	0.00124	CcSEcCtD
Sitaxentan—Pain—Niacin—atherosclerosis	0.000135	0.00123	CcSEcCtD
Sitaxentan—Fatigue—Pravastatin—atherosclerosis	0.000134	0.00123	CcSEcCtD
Sitaxentan—Pain—Pravastatin—atherosclerosis	0.000133	0.00122	CcSEcCtD
Sitaxentan—Constipation—Pravastatin—atherosclerosis	0.000133	0.00122	CcSEcCtD
Sitaxentan—Hypersensitivity—Ezetimibe—atherosclerosis	0.000132	0.00122	CcSEcCtD
Sitaxentan—Asthenia—Lovastatin—atherosclerosis	0.000131	0.00121	CcSEcCtD
Sitaxentan—Asthenia—Ezetimibe—atherosclerosis	0.000129	0.00118	CcSEcCtD
Sitaxentan—Nausea—Rosuvastatin—atherosclerosis	0.000128	0.00118	CcSEcCtD
Sitaxentan—Feeling abnormal—Pravastatin—atherosclerosis	0.000128	0.00117	CcSEcCtD
Sitaxentan—Hypersensitivity—Simvastatin—atherosclerosis	0.000126	0.00116	CcSEcCtD
Sitaxentan—Diarrhoea—Lovastatin—atherosclerosis	0.000125	0.00115	CcSEcCtD
Sitaxentan—Urticaria—Niacin—atherosclerosis	0.000125	0.00115	CcSEcCtD
Sitaxentan—Body temperature increased—Niacin—atherosclerosis	0.000124	0.00114	CcSEcCtD
Sitaxentan—Urticaria—Pravastatin—atherosclerosis	0.000123	0.00113	CcSEcCtD
Sitaxentan—Asthenia—Simvastatin—atherosclerosis	0.000123	0.00113	CcSEcCtD
Sitaxentan—Diarrhoea—Ezetimibe—atherosclerosis	0.000123	0.00113	CcSEcCtD
Sitaxentan—Body temperature increased—Pravastatin—atherosclerosis	0.000123	0.00112	CcSEcCtD
Sitaxentan—Dizziness—Lovastatin—atherosclerosis	0.000121	0.00111	CcSEcCtD
Sitaxentan—Dizziness—Ezetimibe—atherosclerosis	0.000119	0.00109	CcSEcCtD
Sitaxentan—Diarrhoea—Simvastatin—atherosclerosis	0.000117	0.00108	CcSEcCtD
Sitaxentan—Vomiting—Lovastatin—atherosclerosis	0.000117	0.00107	CcSEcCtD
Sitaxentan—Hypersensitivity—Niacin—atherosclerosis	0.000116	0.00106	CcSEcCtD
Sitaxentan—Rash—Lovastatin—atherosclerosis	0.000116	0.00106	CcSEcCtD
Sitaxentan—Dermatitis—Lovastatin—atherosclerosis	0.000115	0.00106	CcSEcCtD
Sitaxentan—Headache—Lovastatin—atherosclerosis	0.000115	0.00105	CcSEcCtD
Sitaxentan—Vomiting—Ezetimibe—atherosclerosis	0.000114	0.00105	CcSEcCtD
Sitaxentan—Hypersensitivity—Pravastatin—atherosclerosis	0.000114	0.00105	CcSEcCtD
Sitaxentan—Dizziness—Simvastatin—atherosclerosis	0.000113	0.00104	CcSEcCtD
Sitaxentan—Rash—Ezetimibe—atherosclerosis	0.000113	0.00104	CcSEcCtD
Sitaxentan—Dermatitis—Ezetimibe—atherosclerosis	0.000113	0.00104	CcSEcCtD
Sitaxentan—Asthenia—Niacin—atherosclerosis	0.000113	0.00104	CcSEcCtD
Sitaxentan—Headache—Ezetimibe—atherosclerosis	0.000113	0.00103	CcSEcCtD
Sitaxentan—Asthenia—Pravastatin—atherosclerosis	0.000111	0.00102	CcSEcCtD
Sitaxentan—Vomiting—Simvastatin—atherosclerosis	0.000109	0.001	CcSEcCtD
Sitaxentan—Nausea—Lovastatin—atherosclerosis	0.000109	0.000999	CcSEcCtD
Sitaxentan—Rash—Simvastatin—atherosclerosis	0.000108	0.000992	CcSEcCtD
Sitaxentan—Dermatitis—Simvastatin—atherosclerosis	0.000108	0.000991	CcSEcCtD
Sitaxentan—Diarrhoea—Niacin—atherosclerosis	0.000108	0.000988	CcSEcCtD
Sitaxentan—Headache—Simvastatin—atherosclerosis	0.000107	0.000985	CcSEcCtD
Sitaxentan—Nausea—Ezetimibe—atherosclerosis	0.000107	0.00098	CcSEcCtD
Sitaxentan—Diarrhoea—Pravastatin—atherosclerosis	0.000106	0.000973	CcSEcCtD
Sitaxentan—Dizziness—Niacin—atherosclerosis	0.000104	0.000955	CcSEcCtD
Sitaxentan—Dizziness—Pravastatin—atherosclerosis	0.000102	0.00094	CcSEcCtD
Sitaxentan—Nausea—Simvastatin—atherosclerosis	0.000102	0.000934	CcSEcCtD
Sitaxentan—Vomiting—Niacin—atherosclerosis	0.0001	0.000918	CcSEcCtD
Sitaxentan—Rash—Niacin—atherosclerosis	9.93e-05	0.000911	CcSEcCtD
Sitaxentan—Dermatitis—Niacin—atherosclerosis	9.92e-05	0.00091	CcSEcCtD
Sitaxentan—Headache—Niacin—atherosclerosis	9.86e-05	0.000905	CcSEcCtD
Sitaxentan—Vomiting—Pravastatin—atherosclerosis	9.85e-05	0.000904	CcSEcCtD
Sitaxentan—Rash—Pravastatin—atherosclerosis	9.77e-05	0.000897	CcSEcCtD
Sitaxentan—Dermatitis—Pravastatin—atherosclerosis	9.76e-05	0.000896	CcSEcCtD
Sitaxentan—Headache—Pravastatin—atherosclerosis	9.71e-05	0.000891	CcSEcCtD
Sitaxentan—Nausea—Niacin—atherosclerosis	9.35e-05	0.000858	CcSEcCtD
Sitaxentan—Nausea—Pravastatin—atherosclerosis	9.21e-05	0.000845	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—LEP—atherosclerosis	2.51e-05	0.000362	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	2.5e-05	0.00036	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CAV1—atherosclerosis	2.49e-05	0.000359	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—APOA1—atherosclerosis	2.48e-05	0.000358	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	2.45e-05	0.000353	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—SOCS3—atherosclerosis	2.4e-05	0.000347	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PLTP—atherosclerosis	2.4e-05	0.000346	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—ESR1—atherosclerosis	2.4e-05	0.000346	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—F2—atherosclerosis	2.37e-05	0.000341	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	2.36e-05	0.00034	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—LDLRAP1—atherosclerosis	2.33e-05	0.000336	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MMP3—atherosclerosis	2.32e-05	0.000335	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IGF2—atherosclerosis	2.31e-05	0.000333	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	2.28e-05	0.000328	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—PIK3CG—atherosclerosis	2.26e-05	0.000327	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—APOB—atherosclerosis	2.24e-05	0.000324	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—CXCL8—atherosclerosis	2.22e-05	0.000321	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	2.22e-05	0.000321	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	2.21e-05	0.000319	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—EDN1—atherosclerosis	2.21e-05	0.000318	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	2.2e-05	0.000317	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CCL5—atherosclerosis	2.19e-05	0.000316	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PLTP—atherosclerosis	2.19e-05	0.000316	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—MAPK3—atherosclerosis	2.17e-05	0.000313	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	2.17e-05	0.000312	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	2.15e-05	0.00031	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—INS—atherosclerosis	2.14e-05	0.000309	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—LPL—atherosclerosis	2.14e-05	0.000309	CbGpPWpGaD
Sitaxentan—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	2.14e-05	0.000308	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CCL2—atherosclerosis	2.11e-05	0.000304	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PRKCG—atherosclerosis	2.08e-05	0.0003	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ABCG8—atherosclerosis	2.08e-05	0.0003	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—LTA4H—atherosclerosis	2.08e-05	0.0003	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IGF1—atherosclerosis	2.07e-05	0.000299	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	2.06e-05	0.000296	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—SPP1—atherosclerosis	2.03e-05	0.000293	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	2.03e-05	0.000293	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CXCL8—atherosclerosis	2.02e-05	0.000291	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	2.02e-05	0.000291	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	2e-05	0.000289	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—SERPINE1—atherosclerosis	1.97e-05	0.000284	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	1.96e-05	0.000282	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	1.94e-05	0.00028	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ABCG8—atherosclerosis	1.9e-05	0.000274	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—LTA4H—atherosclerosis	1.9e-05	0.000274	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NOS3—atherosclerosis	1.88e-05	0.000271	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PDGFB—atherosclerosis	1.88e-05	0.000271	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	1.87e-05	0.00027	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—AGT—atherosclerosis	1.83e-05	0.000264	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—LEP—atherosclerosis	1.8e-05	0.000259	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—APOE—atherosclerosis	1.8e-05	0.000259	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CAV1—atherosclerosis	1.78e-05	0.000257	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—APOA1—atherosclerosis	1.78e-05	0.000256	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	1.77e-05	0.000255	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	1.73e-05	0.000249	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—ESR1—atherosclerosis	1.71e-05	0.000247	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—F2—atherosclerosis	1.69e-05	0.000244	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CXCL8—atherosclerosis	1.67e-05	0.00024	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ABCG1—atherosclerosis	1.65e-05	0.000237	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PIK3CG—atherosclerosis	1.62e-05	0.000234	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—AKT1—atherosclerosis	1.61e-05	0.000232	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—IL6—atherosclerosis	1.59e-05	0.000229	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	1.58e-05	0.000227	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—MAPK3—atherosclerosis	1.55e-05	0.000224	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—FABP4—atherosclerosis	1.55e-05	0.000223	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—LCAT—atherosclerosis	1.55e-05	0.000223	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	1.54e-05	0.000221	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—INS—atherosclerosis	1.53e-05	0.000221	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—APOA4—atherosclerosis	1.52e-05	0.000219	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CCL2—atherosclerosis	1.51e-05	0.000218	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MMP9—atherosclerosis	1.51e-05	0.000218	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ABCG1—atherosclerosis	1.5e-05	0.000216	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NFKB1—atherosclerosis	1.49e-05	0.000215	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CYP7A1—atherosclerosis	1.49e-05	0.000215	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IGF1—atherosclerosis	1.48e-05	0.000214	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MAPK8—atherosclerosis	1.47e-05	0.000212	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—AKT1—atherosclerosis	1.46e-05	0.000211	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PLTP—atherosclerosis	1.44e-05	0.000208	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.42e-05	0.000205	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—FABP4—atherosclerosis	1.41e-05	0.000203	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—LCAT—atherosclerosis	1.41e-05	0.000203	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—SERPINE1—atherosclerosis	1.41e-05	0.000203	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—APOA4—atherosclerosis	1.38e-05	0.0002	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CYP27A1—atherosclerosis	1.38e-05	0.000199	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CYP7A1—atherosclerosis	1.36e-05	0.000196	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.36e-05	0.000196	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—VEGFA—atherosclerosis	1.35e-05	0.000195	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NOS3—atherosclerosis	1.35e-05	0.000194	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—STAT3—atherosclerosis	1.34e-05	0.000193	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.32e-05	0.000191	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—APOA2—atherosclerosis	1.31e-05	0.000189	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PLA2G2A—atherosclerosis	1.31e-05	0.000189	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ALOX5AP—atherosclerosis	1.31e-05	0.000189	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ALOX15—atherosclerosis	1.31e-05	0.000189	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.3e-05	0.000187	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ABCG5—atherosclerosis	1.29e-05	0.000186	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.29e-05	0.000186	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MAPK3—atherosclerosis	1.28e-05	0.000185	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CYP27A1—atherosclerosis	1.26e-05	0.000181	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.25e-05	0.000181	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.25e-05	0.000181	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—LPA—atherosclerosis	1.25e-05	0.00018	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—TGFB1—atherosclerosis	1.24e-05	0.000179	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.24e-05	0.000179	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—BGN—atherosclerosis	1.21e-05	0.000174	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.21e-05	0.000174	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.2e-05	0.000173	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—APOA5—atherosclerosis	1.2e-05	0.000172	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CXCL8—atherosclerosis	1.19e-05	0.000172	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ALOX15—atherosclerosis	1.19e-05	0.000172	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	1.19e-05	0.000172	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—APOA2—atherosclerosis	1.19e-05	0.000172	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	1.19e-05	0.000172	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ABCG5—atherosclerosis	1.18e-05	0.00017	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.18e-05	0.00017	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.16e-05	0.000167	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—AKT1—atherosclerosis	1.15e-05	0.000166	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	1.15e-05	0.000166	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.14e-05	0.000164	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—LPA—atherosclerosis	1.14e-05	0.000164	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—IL6—atherosclerosis	1.13e-05	0.000164	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.13e-05	0.000163	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.12e-05	0.000162	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ALOX5—atherosclerosis	1.11e-05	0.00016	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—BGN—atherosclerosis	1.1e-05	0.000159	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.09e-05	0.000158	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—APOA5—atherosclerosis	1.09e-05	0.000157	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MMP9—atherosclerosis	1.08e-05	0.000156	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NFKB1—atherosclerosis	1.07e-05	0.000154	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.06e-05	0.000153	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MAPK8—atherosclerosis	1.05e-05	0.000151	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.05e-05	0.000151	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—AKT1—atherosclerosis	1.05e-05	0.000151	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.04e-05	0.00015	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.03e-05	0.000148	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.03e-05	0.000148	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.03e-05	0.000148	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.01e-05	0.000146	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—NAMPT—atherosclerosis	9.97e-06	0.000144	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	9.91e-06	0.000143	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—LIPC—atherosclerosis	9.91e-06	0.000143	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ABCG1—atherosclerosis	9.9e-06	0.000143	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—APOC3—atherosclerosis	9.85e-06	0.000142	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—LDLR—atherosclerosis	9.79e-06	0.000141	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—VEGFA—atherosclerosis	9.69e-06	0.00014	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—STAT3—atherosclerosis	9.6e-06	0.000138	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CETP—atherosclerosis	9.56e-06	0.000138	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IL6—atherosclerosis	9.37e-06	0.000135	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	9.36e-06	0.000135	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—LCAT—atherosclerosis	9.3e-06	0.000134	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—FABP4—atherosclerosis	9.3e-06	0.000134	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MAPK3—atherosclerosis	9.17e-06	0.000132	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—SCARB1—atherosclerosis	9.15e-06	0.000132	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—APOA4—atherosclerosis	9.13e-06	0.000132	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—NAMPT—atherosclerosis	9.09e-06	0.000131	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	9.04e-06	0.00013	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—LIPC—atherosclerosis	9.03e-06	0.00013	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—APOC3—atherosclerosis	8.98e-06	0.000129	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CYP7A1—atherosclerosis	8.97e-06	0.000129	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—LDLR—atherosclerosis	8.92e-06	0.000129	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	8.91e-06	0.000129	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TGFB1—atherosclerosis	8.9e-06	0.000128	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CETP—atherosclerosis	8.72e-06	0.000126	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—HMGCR—atherosclerosis	8.64e-06	0.000125	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—AKT1—atherosclerosis	8.64e-06	0.000125	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—SCARB1—atherosclerosis	8.35e-06	0.00012	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CYP27A1—atherosclerosis	8.29e-06	0.00012	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	8.13e-06	0.000117	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—HMGCR—atherosclerosis	7.88e-06	0.000114	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	7.86e-06	0.000113	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ALOX15—atherosclerosis	7.86e-06	0.000113	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	7.86e-06	0.000113	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—APOA2—atherosclerosis	7.86e-06	0.000113	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	7.8e-06	0.000112	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ABCG5—atherosclerosis	7.76e-06	0.000112	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ABCA1—atherosclerosis	7.7e-06	0.000111	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—LPA—atherosclerosis	7.5e-06	0.000108	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—BGN—atherosclerosis	7.26e-06	0.000105	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—APOA5—atherosclerosis	7.19e-06	0.000104	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	7.11e-06	0.000103	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ABCA1—atherosclerosis	7.02e-06	0.000101	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	6.92e-06	9.98e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL6—atherosclerosis	6.7e-06	9.67e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ALOX5—atherosclerosis	6.68e-06	9.64e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—HMOX1—atherosclerosis	6.61e-06	9.53e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—APOB—atherosclerosis	6.33e-06	9.13e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—AKT1—atherosclerosis	6.18e-06	8.92e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GSTM1—atherosclerosis	6.16e-06	8.88e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—LPL—atherosclerosis	6.05e-06	8.72e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—HMOX1—atherosclerosis	6.03e-06	8.69e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—NAMPT—atherosclerosis	6e-06	8.65e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—LIPC—atherosclerosis	5.96e-06	8.59e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—APOC3—atherosclerosis	5.92e-06	8.54e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GPX1—atherosclerosis	5.9e-06	8.51e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—LDLR—atherosclerosis	5.88e-06	8.49e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—APOB—atherosclerosis	5.77e-06	8.33e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CETP—atherosclerosis	5.75e-06	8.29e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CD36—atherosclerosis	5.74e-06	8.28e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GSTM1—atherosclerosis	5.62e-06	8.1e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—LPL—atherosclerosis	5.51e-06	7.95e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—SCARB1—atherosclerosis	5.5e-06	7.94e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—MTHFR—atherosclerosis	5.44e-06	7.85e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GPX1—atherosclerosis	5.38e-06	7.76e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PPARA—atherosclerosis	5.34e-06	7.7e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CD36—atherosclerosis	5.24e-06	7.55e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—HMGCR—atherosclerosis	5.2e-06	7.5e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—AGT—atherosclerosis	5.17e-06	7.46e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—APOE—atherosclerosis	5.07e-06	7.31e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CAV1—atherosclerosis	5.02e-06	7.24e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—APOA1—atherosclerosis	5.01e-06	7.22e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—MTHFR—atherosclerosis	4.96e-06	7.16e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PPARA—atherosclerosis	4.87e-06	7.02e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—AGT—atherosclerosis	4.72e-06	6.8e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ABCA1—atherosclerosis	4.63e-06	6.68e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—APOE—atherosclerosis	4.62e-06	6.66e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CAV1—atherosclerosis	4.58e-06	6.6e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PIK3CG—atherosclerosis	4.57e-06	6.6e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—APOA1—atherosclerosis	4.57e-06	6.59e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PPARG—atherosclerosis	4.41e-06	6.37e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—INS—atherosclerosis	4.33e-06	6.24e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PIK3CG—atherosclerosis	4.17e-06	6.01e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PPARG—atherosclerosis	4.02e-06	5.8e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—HMOX1—atherosclerosis	3.97e-06	5.73e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ALB—atherosclerosis	3.97e-06	5.72e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—INS—atherosclerosis	3.95e-06	5.69e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—APOB—atherosclerosis	3.81e-06	5.49e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—NOS3—atherosclerosis	3.8e-06	5.48e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GSTM1—atherosclerosis	3.7e-06	5.34e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—LPL—atherosclerosis	3.64e-06	5.24e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ALB—atherosclerosis	3.62e-06	5.22e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GPX1—atherosclerosis	3.55e-06	5.12e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PTGS2—atherosclerosis	3.47e-06	5.01e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—NOS3—atherosclerosis	3.46e-06	4.99e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CD36—atherosclerosis	3.45e-06	4.98e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.27e-06	4.72e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PPARA—atherosclerosis	3.21e-06	4.63e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PTGS2—atherosclerosis	3.17e-06	4.57e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—AGT—atherosclerosis	3.11e-06	4.49e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—APOE—atherosclerosis	3.05e-06	4.39e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CAV1—atherosclerosis	3.02e-06	4.35e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—APOA1—atherosclerosis	3.01e-06	4.34e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.75e-06	3.97e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PPARG—atherosclerosis	2.65e-06	3.83e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—INS—atherosclerosis	2.6e-06	3.75e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ALB—atherosclerosis	2.39e-06	3.44e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—NOS3—atherosclerosis	2.28e-06	3.29e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.09e-06	3.01e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—AKT1—atherosclerosis	1.75e-06	2.52e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—AKT1—atherosclerosis	1.59e-06	2.29e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—AKT1—atherosclerosis	1.05e-06	1.51e-05	CbGpPWpGaD
